The proportion of CD8+ TSCM and CD4+ and CD8+ TCM cells were lower, while CD4+ effector memory T (TEM) cells and CD4+ and CD8+ terminal effector T (TEF) cells were higher in CML patients compared with HIs. This evidence concerns the gene CD4 and chronic myelogenous leukemia, BCR-ABL1 positive.